|Cat #||Size||Price||Quantity Check Availability||Save|
|763502||10 µg||190,00 CHF|
Bioinformatic homology analysis reveals that Oncostatin M (OSM) has a similar composition and structure as LIF, G-CSF, and IL-6; this suggests that these genes were derived by duplication of a common ancestral gene. In fact, many of its biological functions are shared with LIF. The receptor systems for OSM differ in composition between man and mouse. Rat oncostatin M receptor has 83% identity with the mouse receptor, and 58% identity with the human receptor. Rat oncostatin M has 72.1% and 51.4% identity with the mouse and human proteins respectively. Thus, it is possible the rat oncostatin M and its receptor may share more similarities with the mouse ligand –receptor system. Human OSM binds two types of OSM receptor (OSMR) complexes. The type I receptor complex is composed of gp130 (IL-6 signal transducer) and LIF receptor β (LIFRβ) subunits. The type II receptor is constituted by the gp130 receptor and the OSMR β-chain. The murine ortholog, which has high affinity binding sites, binds only to the type II OSMR/gp130 receptor complex. Human OSM efficiently activates signal transduction in murine cells; nevertheless, it utilizes only the type I LIFR/gp130 heterodimer on these cells. However, mouse OSM is unable to stimulate human cells. OSM shares the OSMRβ-chain with the IL-31 receptor complex. The OSMRβ subunit is expressed by fibroblasts, endothelial, hepatic, lung, and hematopoietic cells. Pro inflammatory properties of OSM have been reported in the skin, adipose tissue, lung, heart, and liver. OSM triggers acute phase protein synthesis on hepatocytes. Rat OSM inhibits proliferation of rat oval cells (hepatic progenitors in the adult liver, that participate in the liver regeneration) inducing differentiation to hepatocytes. Rat OSM is highly expressed in the late fetal and neonatal testis, studies in vitro suggested that rat OSM plays a role in the regulation of Leydig cell progenitor formation.Product Details
- Rat Oncostatin M, amino acids (Lys26-Arg239) (Accession NP_001006962.1) was expressed in E. coli. The amino terminus contains Met.
- Molecular Mass
- The 215 amino acid recombinant protein has a predicted molecular mass of approximately 24.4 kD. The predicted N-terminal amino acid is Met.
- > 98% as determined by Coomassie stained SDS-PAGE and HPLC analyses.
- Lyophilized from 0.22 µm filtered protein solution in PBS, pH7.2.
- Endotoxin Level
- Less than 0.1 ng/ per µg cytokine (1.0 EU/ µg) as determined by the LAL method.
- Storage & Handling
- Unopened vial can be stored between 2°C and 8°C for one month, or at -20°C to -70°C for one year. For maximum results, quick spin vial prior to opening. Reconstitute in water to a concentration of 0.1-1.0 mg/ml. Do not vortex. It is recommended to further dilute in a buffer (PBS, HPBS, DPBS, or EBSS) containing a carrier protein such as 0.1% BSA and stored in working aliquots at -20°C to -70°C. After reconstitution, it can be stored at -20°C to -70°C for three months. Avoid repeated freeze/thaw cycles.
- Rat Oncostatin M induces the proliferation of rat C6 glioma cells. The ED50 = 3 — 5 µg/ml.
- Recommended Usage
- Product Citations
Activated monocyte, macrophages, T-lymphocyte, skin-infiltrating T cells, and dendritic cells.
- Proinflammatory mediator, keratinocyte activator, induces acute phase protein synthesis, hematopoiesis, bone remodeling, angiogenesis, and cardiac remodeling.
- Keratinocytes, fibroblasts, endothelial, hepatic, lung, hematopoietic cells, epithelial cells, and smooth muscle cells.
- Type II OSMR/gp130 receptor complex.
- Cell Type
- Embryonic Stem Cells, Hematopoietic stem and progenitors
- Biology Area
- Cell Proliferation and Viability, Immunology, Stem Cells
- Molecular Family
- Cytokines/Chemokines, Growth Factors
- Antigen References
1. Lindberg RA, et al. 1998. Mol. Cell. Biol. 18:3357.
2. Rose TM, Bruce AG. 1991. Proc. Natl. Acad. Sci. USA 88:8641.
3. Mosley B, et al. 1996. J. Biol. Chem. 271:32635.
4. Dillon SR, et al. 2004. Nat. Immunol. 5:752.
5. Okaya A, et al. 2005. Am. J. Pathol. 166:709.
6. Boniface K, et al. 2007. J. Immunol. 178:4615.
7. Teerds KJ, et al. 2007. Reprod. Biol. Endocrinol. 5:43.
8. Drechsler J, et al. 2012. PLoS One 7(8):e43155.
9. Beigel F, et al. 2014. PLoS One 9(4):e93498.
10. Schnittker D, et al. 2013. Mediators Inflamm. 2013:317503.
- Gene ID
- 289747 View all products for this Gene ID
- View information about Oncostatin M on UniProt.org
- Why choose BioLegend recombinant proteins?
• Each lot of product is quality-tested for bioactivity as indicated on the data sheet.
• Greater than 95% Purity or higher, tested on every lot of product.
• 100% Satisfaction Guarantee for quality performance, stability, and consistency.
• Ready-to-use liquid format saves time and reduces challenges associated with reconstitution.
• Bulk and customization available. Contact us.
• Learn more about our Recombinant Proteins.
- How does the activity of your recombinant proteins compare to competitors?
We quality control each and every lot of recombinant protein. Not only do we check its bioactivity, but we also compare it against other commercially available recombinant proteins. We make sure each recombinant protein’s activity is at least as good as or better than the competition’s. In order to provide you with the best possible product, we ensure that our testing process is rigorous and thorough. If you’re curious and eager to make the switch to BioLegend recombinants, contact your sales representative today!
- What is the specific activity or ED50 of my recombinant protein?
The specific activity range of the protein is indicated on the product datasheets. Because the exact activity values on a per unit basis can largely fluctuate depending on a number of factors, including the nature of the assay, cell density, age of cells/passage number, culture media used, and end user technique, the specific activity is best defined as a range and we guarantee the specific activity of all our lots will be within the range indicated on the datasheet. Please note this only applies to recombinants labeled for use in bioassays. ELISA standard recombinant proteins are not recommended for bioassay usage as they are not tested for these applications.
- Have your recombinants been tested for stability?
Our testing shows that the recombinant proteins are able to withstand room temperature for a week without losing activity. In addition the recombinant proteins were also found to withstand four cycles of freeze and thaw without losing activity.
- Does specific activity of a recombinant protein vary between lots?
Specific activity will vary for each lot and for the type of experiment that is done to validate it, but all passed lots will have activity within the established ED50 range for the product and we guarantee that our products will have lot-to-lot consistency. Please conduct an experiment-specific validation to find the optimal ED50 for your system.
- How do you convert activity as an ED50 in ng/ml to a specific activity in Units/mg?
- Use formula Specific activity (Units/mg) = 10e6/ ED50 (ng/mL)